DMGV Is a Rheostat of T Cell Survival and a Potential Therapeutic for Inflammatory Diseases and Cancers
Activated effector T cells (Teff) and/or compromised regulatory T cells (Treg) underlie many chronic inflammatory diseases. We discovered a novel pathway to regulate survival and expansion of Teff without compromising Treg survival and a potential therapeutic to treat these diseases. We found dimeth...
Main Authors: | Fengyuan Mandy Yang, Liya Shen, Dengxia Denise Fan, Kuan-Hung Chen, Jongdae Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.918241/full |
Similar Items
-
Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study
by: Julie Poirier, et al.
Published: (2021-11-01) -
Arginine metabolomics in mood disorders
by: Angelo Zinellu, et al.
Published: (2024-03-01) -
Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method
by: Yuta Yoshino, et al.
Published: (2021-04-01) -
Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
by: Christoffer Nyborg, et al.
Published: (2021-08-01) -
Effect of Hyperbaric Oxygenation on Blood Cytokines and Arginine Derivatives; No Evidence for Induction of Inflammation or Endothelial Injury
by: Jacek Siewiera, et al.
Published: (2021-11-01)